Selected research
Industry Research
Anthelmintic Drugs Industry Research Report 2026
Market perspective
The global Anthelmintic Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anthelmintic Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anthelmintic Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anthelmintic Drugs include Sun Pharmaceutical Industries, Johnson & Johnson, Novartis, Merck, Pfizer, Bayer, Mankind Pharma and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anthelmintic Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anthelmintic Drugs Market by Company
Sun Pharmaceutical Industries
Johnson & Johnson
Novartis
Merck
Pfizer
Bayer
Mankind Pharma
Cipla
Anthelmintic Drugs Segment by Type
Oral Drugs
Injectables
Anthelmintic Drugs Segment by Application
For Human
For Animal
Anthelmintic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthelmintic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anthelmintic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthelmintic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anthelmintic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anthelmintic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anthelmintic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Drugs
- Injectables
Applications
- For Human
- For Animal
Companies covered
- Sun Pharmaceutical Industries
- Johnson & Johnson
- Novartis
- Merck
- Pfizer
- Bayer
- Mankind Pharma
- Cipla
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anthelmintic Drugs Market Size (2021-2032)
- 2.2.2 Global Anthelmintic Drugs Sales (2021-2032)
- 2.2.3 Global Anthelmintic Drugs Market Average Price (2021-2032)
- 2.3 Anthelmintic Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Drugs
- 2.3.3 Injectables
- 2.4 Anthelmintic Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 For Human
- 2.4.3 For Animal
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anthelmintic Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anthelmintic Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Anthelmintic Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Anthelmintic Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Anthelmintic Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anthelmintic Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anthelmintic Drugs, Product Type & Application
- 3.8 Global Manufacturers of Anthelmintic Drugs, Established Date
- 3.9 Global Anthelmintic Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries
- 4.1.1 Sun Pharmaceutical Industries Company Information
- 4.1.2 Sun Pharmaceutical Industries Business Overview
- 4.1.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Anthelmintic Drugs Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Anthelmintic Drugs Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Anthelmintic Drugs Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Anthelmintic Drugs Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Anthelmintic Drugs Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Bayer
- 4.6.1 Bayer Company Information
- 4.6.2 Bayer Business Overview
- 4.6.3 Bayer Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bayer Anthelmintic Drugs Product Portfolio
- 4.6.5 Bayer Recent Developments
- 4.7 Mankind Pharma
- 4.7.1 Mankind Pharma Company Information
- 4.7.2 Mankind Pharma Business Overview
- 4.7.3 Mankind Pharma Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mankind Pharma Anthelmintic Drugs Product Portfolio
- 4.7.5 Mankind Pharma Recent Developments
- 4.8 Cipla
- 4.8.1 Cipla Company Information
- 4.8.2 Cipla Business Overview
- 4.8.3 Cipla Anthelmintic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cipla Anthelmintic Drugs Product Portfolio
- 4.8.5 Cipla Recent Developments
5 Global Anthelmintic Drugs Market Scenario by Region
- 5.1 Global Anthelmintic Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anthelmintic Drugs Sales by Region: 2021-2032
- 5.2.1 Global Anthelmintic Drugs Sales by Region: 2021-2026
- 5.2.2 Global Anthelmintic Drugs Sales by Region: 2027-2032
- 5.3 Global Anthelmintic Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Anthelmintic Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Anthelmintic Drugs Revenue by Region: 2027-2032
- 5.4 North America Anthelmintic Drugs Market Facts & Figures by Country
- 5.4.1 North America Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anthelmintic Drugs Sales by Country (2021-2032)
- 5.4.3 North America Anthelmintic Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anthelmintic Drugs Market Facts & Figures by Country
- 5.5.1 Europe Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anthelmintic Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Anthelmintic Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anthelmintic Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anthelmintic Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anthelmintic Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anthelmintic Drugs Market Facts & Figures by Country
- 5.7.1 South America Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anthelmintic Drugs Sales by Country (2021-2032)
- 5.7.3 South America Anthelmintic Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anthelmintic Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anthelmintic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anthelmintic Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anthelmintic Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anthelmintic Drugs Sales by Type (2021-2032)
- 6.1.1 Global Anthelmintic Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Anthelmintic Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Anthelmintic Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Anthelmintic Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anthelmintic Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Anthelmintic Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anthelmintic Drugs Sales by Application (2021-2032)
- 7.1.1 Global Anthelmintic Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Anthelmintic Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Anthelmintic Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Anthelmintic Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anthelmintic Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Anthelmintic Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anthelmintic Drugs Value Chain Analysis
- 8.1.1 Anthelmintic Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anthelmintic Drugs Production Mode & Process
- 8.2 Anthelmintic Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anthelmintic Drugs Distributors
- 8.2.3 Anthelmintic Drugs Customers
9 Global Anthelmintic Drugs Analyzing Market Dynamics
- 9.1 Anthelmintic Drugs Industry Trends
- 9.2 Anthelmintic Drugs Industry Drivers
- 9.3 Anthelmintic Drugs Industry Opportunities and Challenges
- 9.4 Anthelmintic Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst